This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sell These 5 Toxic Stocks Before It's Too Late


First up is Amgen (AMGN - Get Report), the $63 billion biopharmaceutical stock. For the last few weeks, Amgen had been looking bullish -- until shares broke down below support, that is. A failed bullish pattern is generally worse than an outright bearish pattern, and AMGN has been proving that point with its price action for the last few trading sessions.

Amgen had been forming a an ascending triangle pattern, a bullish setup that's formed by horizontal resistance to the upside at $90 and uptrending support below shares. Ultimately, the selling pressure at support proved stronger than buyers had figured, and when bids disappeared at that support line, this stock went into freefall. In a big way, AMGN is a cautionary tale of why it's critical to wait for a breakout to actually happen before jumping onboard a breakout trade.

Now AMGN looks likely to resolve further to the downside. Investors looking for an exit should sell now before January 23 earnings hit - while they could put shares back on track, the headline risk coupled with a bearish chart make it too much of a gamble...
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AMGN $157.27 -2.00%
BHP $31.56 1.50%
MSFT $49.91 0.02%
RYAAY $80.80 -1.10%
REGN $376.23 -3.90%


Chart of I:DJI
DOW 17,717.86 -112.90 -0.63%
S&P 500 2,068.87 -6.94 -0.33%
NASDAQ 4,788.6690 -16.6220 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs